Ads
related to: pfizer
Search results
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 23 hours agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Strong trial results for Pfizer lung cancer drug
The Raw Story· 10 hours agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 1 day agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Pfizer drug extends life for people with rare form of lung cancer
AFP via Yahoo News· 1 day agoA Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival...
3 Stocks to Buy for Huge Income
Motley Fool via Yahoo Finance· 9 hours agoToday, we will be looking at three dividend stocks that pay huge dividends, all with yields above 5%, one of which is Pfizer (NYSE: PFE). Check out this...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
AOL· 2 hours agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a setback for former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim ...
Delaware Judge Lets More Than 70,000 Zantac Lawsuits Go Forward
US News & World Report· 2 hours agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a setback for former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim ...
How To Earn $500 A Month From Pfizer Stock
Benzinga· 1 day agoShares of Pfizer Inc. PFE closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 3 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 1 day agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year —...
